Content of RANTES, IL-8 and MIP-1β chemokines in platelet lysates obtained from donor blood
- 作者: Shupletsova V.V.1, Melashchenko O.B.1, Gazatova N.D.1, Khaziakhmatova O.G.1, Minina A.S.1, Kopteva A.1, Kabanchuk N.A.2, Pervenetskaya T.N.2, Goncharov A.G.1, Litvinova L.S.1
-
隶属关系:
- Immanuel Kant Baltic Federal University
- Blood Transfusion Station of the Kaliningrad Region
- 期: 卷 28, 编号 4 (2025)
- 页面: 931-938
- 栏目: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/1028-7221/article/view/333253
- DOI: https://doi.org/10.46235/1028-7221-17237-COR
- ID: 333253
如何引用文章
全文:
详细
Growth supplements obtained from animal sera have a rather variable range of a specific growth factor contents and are subject to potential contamination. Moreover, the growth supplements obtained from animal raw materials contain a composition of proteins, vitamins and microelements necessary for full-fledged cell growth, and one may overcome these drawbacks by replacing them with a product obtained from human donor blood. Platelet lysate contains biologically active molecules derived from endogenous granules of these blood elements. Concentration of distinct biocomponents in the resulting product is variable, depending not only on gender and blood group, but also on other, as yet unidentified individual characteristics. The aim of this study was to examine the content of some chemokines, in particular, RANTES, MIP-1β and IL-8, in platelet lysates obtained from healthy donors. The highest concentrations of MIP-1β cytokine were noted in Rh-negative donors, in females with blood group III, and in males with the IV. blood group. The highest IL-8 contents in platelet lysate were also recorded in Rh-negative, group IV men and women. Platelet lysate of volunteers with the II blood group (men, Rh-negative; women, Rh-positive) contained the highest amount of RANTES. Significant differences were found between the MIP-1β levels in thrombolysate of men and women with the second A (II), and AB (IV) Rh-negative blood groups; between women of the third B (III) blood group with different Rh factors. Moreover, statistically significant differences were found in the RANTES/CCL5 chemokine values in the thrombolysate for the groups of men and women with the second A (II) [with R (+) and R (-)], and AB (IV) blood group (Rh+). Interestingly, in Rh (-) men with the first 0 (I) and second A (II) blood groups, the content of chemokine RANTES/CCL5 in the blood thrombolysate significantly exceeded similar values in the blood obtained from Rh-positive men. Conclusion: The relationship between the donors’ belonging to a particular blood group and the content of these chemokines is not yet clear. Future studies with deep bioinformatics analysis will reveal the unclear interrelations between these indicators.
作者简介
Valeria Shupletsova
Immanuel Kant Baltic Federal University
Email: vshupletsova@mail.ru
ORCID iD: 0000-0001-7243-9731
PhD (Biology), Senior Researcher, Center for Immunology and Cellular Biotechnology
俄罗斯联邦, 6 Gaidar St, room 301, Kaliningrad, 236022Olga Melashchenko
Immanuel Kant Baltic Federal University
Email: OMelashchenko@kantiana.ru
ORCID iD: 0000-0002-0892-1168
Researcher, Center for Immunology and Cellular Biotechnology
俄罗斯联邦, KaliningradNatalya Gazatova
Immanuel Kant Baltic Federal University
Email: n_gazatova@mail.ru
ORCID iD: 0000-0002-4646-3436
Senior Researcher, Head, Laboratory of Experimental Studies of Blood Products, Center for Immunology and Cellular Biotechnology
俄罗斯联邦, KaliningradOlga Khaziakhmatova
Immanuel Kant Baltic Federal University
Email: hazik36@mail.ru
ORCID iD: 0000-0002-5525-3529
PhD (Biology), Senior Researcher, Center for Immunology and Cellular Biotechnology
俄罗斯联邦, KaliningradAlexandra Minina
Immanuel Kant Baltic Federal University
Email: minina.saschenka@yandex.ru
ORCID iD: 0009-0000-2222-2649
Research Student, Center for Immunology and Cellular Biotechnology
俄罗斯联邦, KaliningradAnastassiya Kopteva
Immanuel Kant Baltic Federal University
编辑信件的主要联系方式.
Email: vohumanaah@gmail.com
ORCID iD: 0009-0002-4722-643X
research student, Center for Immunology and Cellular Biotechnology
俄罗斯联邦, KaliningradNina Kabanchuk
Blood Transfusion Station of the Kaliningrad Region
Email: spk@infomed39.ru
ORCID iD: 0009-0004-9655-4223
Acting Chief Physician
俄罗斯联邦, KaliningradTatyana Pervenetskaya
Blood Transfusion Station of the Kaliningrad Region
Email: pervenetskaia.tatiana@gmail.com
ORCID iD: 0009-0006-0073-5455
Head, Expedition with the Center for Management of Donor Blood Components
俄罗斯联邦, KaliningradAndrey Goncharov
Immanuel Kant Baltic Federal University
Email: agoncharov59@mail.ru
ORCID iD: 0000-0001-6967-8838
PhD (Medicine), Senior Researcher, Center for Immunology and Cellular Biotechnologies
俄罗斯联邦, KaliningradLarisa Litvinova
Immanuel Kant Baltic Federal University
Email: larisalitvinova@yandex.ru
ORCID iD: 0000-0001-5231-6910
PhD, MD (Medicine), Director, Center for Immunology and Cellular Biotechnology
俄罗斯联邦, Kaliningrad参考
- Халиулин А.В., Гусякова О.А., Козлов А.В., Габрильчак А.И. Процессы метаболизма и механизмы регуляции активности тромбоцитов (обзор литературы) // Клиническая лабораторная диагностика, 2019. Т. 64, № 3. С. 164-169. [Khaliulin A.V., Gusyakova O.A., Kozlov A.V., Gabrilchak A.I. Metabolic processes and mechanisms of regulation of platelet activity (literature review). Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics, 2019, Vol. 64, no. 3, pp. 164-169. (In Russ.)]
- Burnouf T., Chou M.L., Lundy D.J., Chuang E.Y., Tseng C.L., Goubran H. Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery. J. Biomed. Sci., 2023, Vol. 30, no. 1, 79. doi: 10.1186/s12929-023-00972-w.
- Cognasse F., Duchez A.C., Audoux E., Ebermeyer T., Arthaud C.A., Prier A., Eyraud M.A., Mismetti P., Garraud O., Bertoletti L., Hamzeh-Cognasse H. Platelets as key factors in inflammation: focus on CD40L/CD40. Front. Immunol., 2022, Vol. 13, 825892. doi: 10.3389/fimmu.2022.825892.
- Cunin P., Nigrovic P.A. Megakaryocytes as immune cells. J. Leukoc. Biol., 2019, Vol. 105, no. 6, pp. 1111-1121.
- Golshan M., Dortaj H., Rajabi M., Omidi Z., Golshan M., Pourentezari M., Rajabi A. Animal origins free products in cell culture media: a new frontier. Cytotechnology, 2025, Vol. 77, no. 1, 12. doi: 10.1007/s10616-024-00666-7.
- Hou Y., Huttenlocher A. Advancing chemokine research: the molecular function of CXCL8. J. Clin. Invest., 2024, Vol. 134, no. 10, e180984. doi: 10.1172/JCI180984.
- Hughes C.E., Nibbs R.J.B. A guide to chemokines and their receptors. FEBS J., 2018, Vol. 285, no. 16, pp. 2944-2971.
- Köhler A., de Filippo K., Hasenberg M., van den Brandt C., Nye E., Hosking M.P., Lane T.E., Männ L., Ransohoff R.M., Hauser A.E., Winter O., Schraven B., Geiger H., Hogg N., Gunzer M. G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood, 2011, Vol. 117, no. 16, pp. 4349-4357.
- Korbecki J., Grochans S., Gutowska I., Barczak K., Baranowska-Bosiacka I. CC Chemokines in a tumor: A review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. Int. J. Mol. Sci., 2020, Vol. 21. no. 20, 7619. doi: 10.3390/ijms21207619.
- Luo H., Li L., Han S., Liu T. The role of monocyte/macrophage chemokines in pathogenesis of osteoarthritis: A review. Int. J. Immunogenet., 2024 , Vol. 51, no. 3, pp. 130-142.
- Matsushima K., Yang D., Oppenheim J. J. Interleukin-8: An evolving chemokine. Cytokine, 2022, Vol. 153, 155828. doi: 10.1016/j.cyto.2022.155828.
- Maurer M., von Stebut E. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol., 2004, Vol. 36, no. 10, pp. 1882-1886.
- Potts K.S., Farley A., Dawson C.A., Rimes J., Biben C., de Graaf C., Potts M.A., Stonehouse O.J., Carmagnac A., Gangatirkar P., Josefsson EC., Anttila C., Amann-Zalcenstein D., Naik S., Alexander W.S., Hilton D.J., Hawkins E.D., Taoudi S. Membrane budding is a major mechanism of in vivo platelet biogenesis. J. Exp. Med., 2020, Vol. 217, no. 9, e20191206. doi: 10.1084/jem.20191206.
- Price P.J. Best practices for media selection for mammalian cells. In Vitro Cell. Dev. Biol. Anim., 2017, Vol. 53, no. 8, pp. 673-681.
- Singh A., Bisht P., Bhattacharya S., Guchhait P. Role of platelet cytokines in dengue virus infection. Front. Cell. Infect. Microbiol., 2020, Vol. 10, 561366. doi: 10.3389/fcimb.2020.561366.
补充文件
